
Fishing wild-type sparing inhibitors of proto-oncogene c-met variants in renal cell carcinoma from a curated tyrosine kinase inhibitor pool using analog-sensitive kinase technology
Keywords: انتخابی; Renal cell carcinoma; c-Met; Tyrosine kinase inhibitor; Selectivity; Missense mutation; Inhibitor response-to-kinase mutation profile;